<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <!-- Homepage with hreflang -->
  <url>
    <loc>https://bioaccessla.com/</loc>
    <lastmod>2026-02-25</lastmod>
    
    <priority>1.0</priority>
    <xhtml:link rel="alternate" hreflang="en" href="https://bioaccessla.com/" />
    <xhtml:link rel="alternate" hreflang="es" href="https://bioaccessla.com/es" />
    <xhtml:link rel="alternate" hreflang="pt-BR" href="https://bioaccessla.com/pt" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://bioaccessla.com/" />
  </url>

  <!-- Spanish Landing with hreflang -->
  <url>
    <loc>https://bioaccessla.com/es</loc>
    <lastmod>2026-02-25</lastmod>
    
    <priority>0.8</priority>
    <xhtml:link rel="alternate" hreflang="en" href="https://bioaccessla.com/" />
    <xhtml:link rel="alternate" hreflang="es" href="https://bioaccessla.com/es" />
    <xhtml:link rel="alternate" hreflang="pt-BR" href="https://bioaccessla.com/pt" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://bioaccessla.com/" />
  </url>

  <!-- Portuguese Landing with hreflang -->
  <url>
    <loc>https://bioaccessla.com/pt</loc>
    <lastmod>2026-02-25</lastmod>
    
    <priority>0.8</priority>
    <xhtml:link rel="alternate" hreflang="en" href="https://bioaccessla.com/" />
    <xhtml:link rel="alternate" hreflang="es" href="https://bioaccessla.com/es" />
    <xhtml:link rel="alternate" hreflang="pt-BR" href="https://bioaccessla.com/pt" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://bioaccessla.com/" />
  </url>

  <!-- Static Pages -->
  <url><loc>https://bioaccessla.com/services</loc><lastmod>2026-03-05</lastmod><priority>0.9</priority></url>
  <url><loc>https://bioaccessla.com/fasttrack</loc><lastmod>2026-03-05</lastmod><priority>0.9</priority></url>
  <url><loc>https://bioaccessla.com/costs-and-timelines</loc><lastmod>2026-02-25</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/site-search-selection</loc><lastmod>2026-02-25</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/solutions</loc><lastmod>2026-02-25</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/innovation-runway</loc><lastmod>2026-02-25</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/market-access</loc><lastmod>2026-03-05</lastmod><priority>0.9</priority></url>
  <url><loc>https://bioaccessla.com/radiopharmaceuticals</loc><lastmod>2026-02-25</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/about</loc><lastmod>2026-02-25</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/case-studies</loc><lastmod>2026-02-25</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/blog</loc><lastmod>2026-02-25</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/contact</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/testimonials</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/glossary</loc><lastmod>2026-02-25</lastmod><priority>0.6</priority></url>
  <url><loc>https://bioaccessla.com/clinical-trial-calculator</loc><lastmod>2026-02-25</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/latam-device-registration-pricing</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/privacy-policy</loc><lastmod>2026-02-25</lastmod><priority>0.3</priority></url>
  <url><loc>https://bioaccessla.com/greenlight-guru</loc><lastmod>2026-03-10</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/first-in-human-cro</loc><lastmod>2026-03-28</lastmod><priority>0.9</priority></url>
  <url><loc>https://bioaccessla.com/early-feasibility-studies</loc><lastmod>2026-03-28</lastmod><priority>0.9</priority></url>

  <!-- Country Landing Pages -->
  <url><loc>https://bioaccessla.com/clinical-trials-colombia</loc><lastmod>2026-03-27</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/clinical-trials-brazil</loc><lastmod>2026-03-27</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/clinical-trials-mexico</loc><lastmod>2026-03-27</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/clinical-trials-panama</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/clinical-trials-el-salvador</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/clinical-trials-paraguay</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>

  <!-- Regulatory Guide Hub & Country Pages -->
  <url><loc>https://bioaccessla.com/regulatory-guide/hub</loc><lastmod>2026-03-27</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/colombia</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/brazil</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/mexico</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/argentina</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/chile</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/peru</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/panama</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/ecuador</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/dominican-republic</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/regulatory-guide/costa-rica</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>

  <!-- Static Blog Posts -->
  <url><loc>https://bioaccessla.com/blog/fda-acceptance-latin-america-fih-study-guide</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/clinical-trial-insurance-latin-america</loc><lastmod>2026-03-11</lastmod><priority>0.7</priority></url>
  <url>
    <loc>https://bioaccessla.com/blog/colombia-clinical-research-bill-191-after-march-2026-elections</loc>
    <lastmod>2026-03-11</lastmod>
    <priority>0.8</priority>
    <xhtml:link rel="alternate" hreflang="en" href="https://bioaccessla.com/blog/colombia-clinical-research-bill-191-after-march-2026-elections" />
    <xhtml:link rel="alternate" hreflang="es" href="https://bioaccessla.com/blog/proyecto-de-ley-191-investigacion-clinica-colombia-elecciones-marzo-2026" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://bioaccessla.com/blog/colombia-clinical-research-bill-191-after-march-2026-elections" />
  </url>
  <url>
    <loc>https://bioaccessla.com/blog/proyecto-de-ley-191-investigacion-clinica-colombia-elecciones-marzo-2026</loc>
    <lastmod>2026-03-11</lastmod>
    <priority>0.8</priority>
    <xhtml:link rel="alternate" hreflang="en" href="https://bioaccessla.com/blog/colombia-clinical-research-bill-191-after-march-2026-elections" />
    <xhtml:link rel="alternate" hreflang="es" href="https://bioaccessla.com/blog/proyecto-de-ley-191-investigacion-clinica-colombia-elecciones-marzo-2026" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://bioaccessla.com/blog/colombia-clinical-research-bill-191-after-march-2026-elections" />
  </url>
  <url><loc>https://bioaccessla.com/blog/how-latin-america-helps-sponsors-meet-fda-diversity-requirements-pivotal-trials</loc><lastmod>2026-03-23</lastmod><priority>0.8</priority></url>
  <url><loc>https://bioaccessla.com/blog/fda-acceptance-latin-america-clinical-data-guide</loc><lastmod>2026-03-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/clinical-trial-costs-latin-america-vs-us-eu-benchmark</loc><lastmod>2026-03-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/radiopharmaceutical-clinical-trials-latin-america</loc><lastmod>2026-03-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/early-feasibility-device-trials-latin-america-glp-gmp-sterility-requirements</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/panama-first-in-human-clinical-trials-medical-devices</loc><lastmod>2026-03-28</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/how-to-compare-cro-proposals-first-in-human-trials-latin-america</loc><lastmod>2026-03-30</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/first-in-human-gene-therapy-trials-latin-america-regulatory-guide</loc><lastmod>2026-04-01</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/us-medical-device-latam-market-entry-strategy-sequence</loc><lastmod>2026-04-03</lastmod><priority>0.7</priority></url>

  <!-- Venezuela Blog Posts (canonical slugs only) -->
  <url><loc>https://bioaccessla.com/blog/venezuela-the-next-frontier-for-clinical-research-in-latin-america</loc><lastmod>2026-03-24</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/understanding-venezuelas-clinical-trial-regulatory-framework-mpps-inhrr-and-sacs</loc><lastmod>2026-03-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/why-medical-device-companies-should-consider-venezuela-for-first-in-human-studies</loc><lastmod>2026-03-26</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/venezuelas-physician-workforce-a-hidden-asset-for-clinical-research</loc><lastmod>2026-03-27</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/conducting-clinical-trials-in-venezuela-a-practical-guide-for-sponsors</loc><lastmod>2026-03-28</lastmod><priority>0.7</priority></url>

  <!-- Team Profiles -->
  <url><loc>https://bioaccessla.com/team/pedro-martinez-clark</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/team/julio-martinez-clark</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/team/william-oneill</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>

  <!-- Case Studies -->
  <url><loc>https://bioaccessla.com/case-studies/axoft</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/newrotex</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/sparta-biomedical</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/inspire-medical</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/pavmed</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/celonova-biosciences</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/motif-neurotech</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/establishment-labs</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/cook-group</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/avantec-vascular</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/clarvista-medical</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/envveno-medical</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/kona-medical</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/regeltec</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/direct-flow-medical</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/ocumedex</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/i-lumen-scientific</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/libella-gene-therapeutics</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/mitralign</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/on-target-molecules</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/avinger</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/intervene</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/tecure</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/synecor</loc><lastmod>2026-02-25</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/case-studies/spinal-stabilization-technologies</loc><lastmod>2026-03-23</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/first-in-human-medical-device-trial-chile</loc><lastmod>2026-03-28</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/invima-clinical-trial-approval-process-colombia</loc><lastmod>2026-03-30</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/cofepris-medical-device-registration-mexico</loc><lastmod>2026-04-01</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/early-feasibility-study-cro-latin-america</loc><lastmod>2026-04-03</lastmod><priority>0.7</priority></url>
  <url><loc>https://bioaccessla.com/blog/medical-device-cro-latin-america</loc><lastmod>2026-04-05</lastmod><priority>0.7</priority></url>
</urlset>